S

Syneos Health Inc
F:8IN

Watchlist Manager
Syneos Health Inc
F:8IN
Watchlist
Price: 40 EUR Market Closed
Market Cap: 4.1B EUR

Operating Margin
Syneos Health Inc

6.3%
Current
8%
Average
3.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
6.3%
=
Operating Profit
342.8m
/
Revenue
5.4B

Operating Margin Across Competitors

No Stocks Found

Syneos Health Inc
Glance View

Syneos Health Inc., a formidable player in the biopharmaceutical realm, makes its mark as a dynamic integrated biopharmaceutical solutions organization. The company skillfully blends clinical development and commercial services to support pharma, biotech, and healthcare companies in navigating the complexities of bringing new therapies to market. With deep roots in clinical trials and commercialization, Syneos leverages its unique position of being involved in both the development and the market launch of new drugs—a dual focus that gives them a competitive advantage. Their business model thrives on partnerships, built on offering tailored solutions that bridge the gap between clinical insights and commercial acumen, allowing their clients to accelerate the journey from innovative ideas to patient impact. At the heart of Syneos Health's profitability are its two main segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions arm is committed to orchestrating the myriad stages of the drug development process, from early-phase trials to regulatory approval. This involves meticulously managing trials, patient recruitment, regulatory submissions, and data science applications to ensure efficacy and safety are satisfactorily demonstrated. Meanwhile, the Commercial Solutions division strategically steers approved products into the market with precision, leveraging an array of marketing, consulting, communications, and operations expertise. This holistic suite of services not only ensures a seamless transition from lab to market but also optimizes the commercial potential of their clients’ innovations, ensuring both regulatory and market success. Through these interwoven facets of clinical and commercial services, Syneos Health carves out a distinct role in the lifecycle of therapeutics development and delivery.

8IN Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
6.3%
=
Operating Profit
342.8m
/
Revenue
5.4B
What is the Operating Margin of Syneos Health Inc?

Based on Syneos Health Inc's most recent financial statements, the company has Operating Margin of 6.3%.

Back to Top